Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma
NCT00181220
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
PI left JHU and is not able to be reached for updates
Conditions
Nasopharyngeal Carcinoma
Interventions
DRUG:
valproic acid
Sponsor
Johns Hopkins University
Collaborators
[object Object]